MVIC AB is a full service CRO specialized in inhalation product development. MVIC AB is located in the Skåne-Copenhagen Medicon Valley area, and offers world class expertise within the field of inhalation, covering the whole value chain of drug discovery and development.
Medicon Valley Inhalation Consortium was formed in 2012 by a number of companies in the Malmö/Lund region. Initially MVIC comprised 10 companies set up by former AstraZeneca employees, with an extensive inhalation expertise. Today MVIC AB is a legal entity and has grown to comprise 24 member companies, with more than 70 inhalation experts together holding over 1000 years of relevant experience. Currently more than 25 of these experts hold a PhD covering a wide range of specific competences, and just as important, MVIC also have the hand-on experts, who can deliver at the bench. As a customer, using MVIC AB as a partner and service provider will give you the edge and versatility of the small specialist company along with the breadth of a larger CRO, in a single contract.
MVIC AB offers pre-clinical services from target validation to candidate drug characterization. Services include:
Complete lead discovery projects, Assay development and screening, in vitro and in vivo testing, DMPK profiling, Pharmacological testing, Biomarker programs and Toxicology plans. Project Management.
MVIC AB offers development services from formulation to device development. Services include:
Solid State characterization, Formulation from pre-clinic to final product, Device development and product characterisation including Fluid dynamics and CFD. Manufacturing up to Phase II/III. Project Management.
MVIC AB offers development services to support clinical and regulatory submissions. Services include:
Regulatory affairs strategy, Clinical trial design, Biomarker strategy, Statistical analysis and Data processing, Documentation and Quality systems. Project Management.